Leonteq Securities’s Coherus Oncology CHRS Stock Holding History
Bought
Maintained
Sold
Other funds holding CHRS
TGY2IT
CM
Leonteq Securities's CHRS Position: Q3 2026 in Review
Leonteq Securities opened a new position in Coherus Oncology (CHRS) in Q3 2026: 30,746 shares worth $37.2K. The stake represents ﹤0.01% of the portfolio and ranks #832 among its holdings.
100 funds tracked by Wall St. Rank hold CHRS as of Q3 2026.
- Leonteq Securities held 30,746 shares of Coherus Oncology worth $37.2K as of Q3 2026.
- Coherus Oncology was a new Leonteq Securities position in Q3 2026.
- Coherus Oncology made up ﹤0.01% of Leonteq Securities's portfolio in Q3 2026, its #832 holding.
- 100 funds tracked by Wall St. Rank held Coherus Oncology as of Q3 2026.
Based on Leonteq Securities's 13F filing for Q3 2026, filed 29 Oct 2026.